Dolutegravir + Emtricitabine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dolutegravir + Emtricitabine, covering 2019-08-09 to 2019-08-09. Get the full timeline:
Most recent: Clinical Trial Update: Dolutegravir Plus Tenofovir/Lamivudine or Emtricitabine in HIV-1 Infected Transgender Women [Phase 4]